entity

CRISPR

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CRISPR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

20Connections
11Hypotheses
5Analyses
10Outgoing
6Incoming

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

CRISPR-Cas9 Gene Editing for Neurodegenerative Diseases

technology · 846 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Novel Therapy Index

idea · 10647 words

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

mechanism · 7227 words

Atypical Parkinsonism

disease · 6876 words

Outgoing (12)

TargetRelationTypeStr
Central Nervous Systemtargetsbrain_region0.95
Epigenetic Modificationsmediatesprocess0.95
Metabolic Reprogrammingpromotesprocess0.90
Mitochondrial Genomeeditsgenome0.90
Adult Neuronstargetscell_type0.85

Incoming (8)

SourceRelationTypeStr
SDA-2026-04-02-gap-crispr-neurodegeneration-20260402investigatesanalysis0.95
Viral Vectormediatescompound0.85
Cell-type-specific essential genesco_associated_withgene0.30
PGC1A, SIRT1, FOXO3, mitochondrial biogenesis genesco_associated_withgene0.30
NURR1, PITX3, neuronal identity transcription factorsco_associated_withgene0.30

Targeting Hypotheses (11)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat 0.517 neurodegeneration CRISPR-based therapeutic approaches for
Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mi 0.511 neurodegeneration CRISPR-based therapeutic approaches for
Context-Dependent CRISPR Activation in Specific Neuronal Sub 0.509 neurodegeneration CRISPR-based therapeutic approaches for
CRISPR-Mediated Mitochondrial Genome Editing for Complex I D 0.491 neurodegeneration CRISPR-based therapeutic approaches for
Cholesterol-CRISPR Convergence Therapy for Neurodegeneration 0.484 neurodegeneration CRISPR-based therapeutic approaches for
Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar 0.479 neurodegeneration CRISPR-based therapeutic approaches for
Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo 0.465 neurodegeneration CRISPR-based therapeutic approaches for
Conditional CRISPR Kill Switches for Aberrant Protein Cleara 0.451 neurodegeneration CRISPR-based therapeutic approaches for
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci 0.451 neurodegeneration CRISPR-based therapeutic approaches for
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon 0.423 neurodegeneration CRISPR-based therapeutic approaches for
Programmable Neuronal Circuit Repair via Epigenetic CRISPR 0.423 neurodegeneration CRISPR-based therapeutic approaches for

Mentioning Analyses (5)

Scientific analyses that reference this entity

What molecular mechanisms explain how KCNJ2 inhibition mitigates TBI-induced neu

neurodegeneration | 2026-04-13 | 0 hypotheses

How can CRISPR systems achieve persistent therapeutic effects while avoiding chr

gene therapy | 2026-04-11 | 0 hypotheses

What delivery mechanisms can achieve therapeutically relevant CRISPR concentrati

drug delivery | 2026-04-10 | 0 hypotheses

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.622

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-02 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] Chua JP, De Calbiac H, Kabashi E, Barmad Autophagy 2022 2
Mismatch repair MLH complexes make distinct contributions to post-replicative mi [PMID:41648604] Casazza KM, Williams GM, Johengen L, Kel bioRxiv 2026 0
Exploring Parkinson's through the Lens of Genomics and Bioinformatics. [PMID:39929729] Menon V Cold Spring Harb Perspect Med 2026 0
A Simple Method for RNA-Seq of Manually Isolated Chromatophores in Oryzias Fishe [PMID:41805030] Goda M, Miyagi A, Sugiwaka K, Watanabe M Dev Growth Differ 2026 0
Phosphate starvation induces root cell-type-specific transcriptional responses a [PMID:41952296] González-García MP, Lanza M, Baca-Gonzál New Phytol 2026 0
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associate [PMID:41576950] ["Ghoochani A", "Heiby J", "Rawat E", "M Cell 2026 0
Decoding Alzheimer's genetic risk through intercellular communication in the hum [PMID:41707523] Lish AM, Young-Pearse TL Current opinion in neurobiolog 2026 0
Neuromodulatory role and therapeutic potential of N 6 -methyladenosine RNA methy [PMID:40618260] Zhang J, Ma W, Liu R, Li X, Yuan Z, Chen Neural regeneration research 2026 0
Single-Cell Atlas of Transcription and Chromatin States Reveals Regulatory Progr [PMID:41676679] Xie Y, Chang L, Zhong G, Rink JA, Báez-B bioRxiv : the preprint server 2026 0
Targeting a Shared Mitophagy Regulator: The SIRT1-FOXO3-DEPP1 Axis Underpins the [PMID:41743852] Zhang Y, Guo X, Wang Q, Xiao L, Liu Q, G Research (Washington, D.C.) 2026 0
Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRI [PMID:41905621] ["Singh R", "Maity P", "Jaiswal C"] Neurochemistry international 2026 0
Targeting Non-coding RNAs in Neurodegeneration: Advances in Therapeutic RNA Moda [PMID:41588889] ["Thakur A", "Chowdhury K", "Kumar A", " Current Alzheimer research 2026 0
Hereditary Polyneuropathies in the Era of Precision Medicine: Genetic Complexity [PMID:41595476] ["Chrysostomaki M", "Chatzi D", "Kyriako Genes 2026 0
Neuroinflammation, Autophagy, and Neurodegeneration: Mechanisms and Therapeutic [PMID:41918200] ["Khanal P", "Balmik A"] CNS & neurological disorders d 2026 0
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disea [PMID:39824182] ["Handsaker R", "Kashin S", "Reed N", "T Cell 2025 0
Whole mitochondrial genome sequencing in individuals with Leber hereditary optic [PMID:40969215] Srilekha S, Ambika S, Hemavathy N, Vidhy Front Neurol 2025 0
Exploring rare mitochondrial DNA in Leber hereditary optic neuropathy. [PMID:41080639] Cao S, Liu Y, Sun M, Zhang Y, Sun Y et a Adv Ophthalmol Pract Res 2025 0
Metabolic rewiring prevents neurodegeneration caused by chronic mitochondrial dy [PMID:41151583] Richhariya S, Shin D, Schlichting M, Ros Current biology : CB 2025 0
Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity. [PMID:39893321] Gumusgoz E, Kasiri S, Youssef I, Verma M Gene therapy 2025 0
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy. [PMID:40108474] Yuan S, Sun R, Shi H, Chapman NM, Hu H, Nature 2025 0